Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial - Iijima, K; Sako, M; Nozu, K (Lancet, 2014)
et al.